Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression
Tetra Pharm Technologies has reached a significant in developing its compound for appetite suppression, TPT0701, following the successful...
top of page
Browse by category
Search
Browse by tag
bottom of page